The goal of the proposed study is to evaluate the efficacy and safety of dronabinol in trichotillomania and other body-focused repetitive behaviors such as skin-picking disorder. 50 subjects with DSM-5 trichotillomania or skin-picking disorder will receive 10 weeks of double-blind dronabinol or placebo. The hypothesis to be tested is that dronabinol will be effective and well tolerated in patients with trichotillomania and/or skin-picking disorder compared to placebo. The proposed study will provide needed data on the treatment of disabling disorders that currently lacks a clearly effective treatment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
NIMH Trichotillomania Symptom Severity Scale (NIMH-TSS)
Timeframe: Assessed every two weeks up to 10 weeks, baseline data reported
Skin Picking Symptom Assessment Scale (SP-SAS)
Timeframe: Assessed every two weeks up to 10 weeks, baseline reported